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Improved  diagnostic  tools  for rapid  detection,  quantitation,  and  subgrouping  of  human  respiratory  syn-
cytial virus  (RSV)  are  needed  to  aid  the  development  and  evaluation  of  novel  intervention  strategies.  A
quantitative  real-time  RT-PCR  using  speciﬁc  locked  nucleic  acid  (LNA)  probes  was  developed  to  iden-
tify RSV  and  to  distinguish  RSV  subgroups  A  and  B  (RSV  LNA  assay).  RSV  subgroup  diversity  and  the
relationship  between  viral  load  and  disease  severity  in  conﬁrmed  RSV  infections  were  also  explored.  264






tiplex Seeplex RV  detection  kit  (Seegene)  and  the  novel  RSV  LNA  assay.  The  LNA  assay  demonstrated  a
signiﬁcantly  higher  sensitivity  than  Seeplex,  improving  overall  detection  rates  from  24%  (64/264)  to  32%
(84/264).  Detection  limits  of 9.0  ×  101 and  6.0  × 102 copies/mL  were  observed  for RSV  A  and  B,  respec-
tively.  RSV  A  was  detected  in  53/84  (63%)  cases,  and  31/84  (37%)  were  positive  for  RSV  B.  This  novel
method  offers  a  rapid,  quantitative,  highly  speciﬁc  and  sensitive  approach  to  laboratory  diagnosis  of  RSV.. Introduction
Human respiratory syncytial virus (RSV) is a Pneumovirus and
 member of the subfamily of Pneumovirinae within the fam-
ly of Paramyxoviridae. Based on differences in the antigenicity
nd nucleotide sequences analysis, RSV strains have been classi-
ed in two major antigenic subgroups, denoted RSV A and RSV B
Sullender, 2000). RSV is a major cause of acute respiratory tract
nfections in children worldwide (Nair et al., 2010; Weber et al.,
998), and is responsible for a large proportion of hospital admis-
ions during infancy and early childhood (Mejias et al., 2005). No
accine is available, and treatment is limited to supportive care
Empey et al., 2010). RSV is also a frequent cause of nosocomial
nfections, and as such may  signiﬁcantly impact the duration of
tay in hospital and healthcare costs during childhood (Macartney
t al., 2000). Data on epidemiology and molecular virological char-
cteristics of RSV isolates circulating in Southeast Asia are limited.
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Diagnosis of RSV infection is typically performed on respira-
tory samples using virus culture, (rapid) antigen detection tests, or
molecular assays (Henrickson, 2004). Real-time reverse transcrip-
tase PCR (RT-PCR) provides a rapid and sensitive tool for detection
of RSV compared to conventional techniques and enables (semi-
)quantitation of viral load (Borg et al., 2003; Dewhurst-Maridor
et al., 2004; do Nascimento et al., 2008; Empey et al., 2010; Falsey
et al., 2003, 2002; Henrickson, 2004; Houben et al., 2010; Hu et al.,
2003; Kuypers et al., 2004; Mentel et al., 2003; Perkins et al.,
2005; van de Pol et al., 2006, 2010; van Elden et al., 2003). The
locked nucleic acid (LNA) technology increases thermal stability
of probe-target interaction and improves discrimination of dif-
ferent nucleic acid targets (Reynisson et al., 2006). The N gene
is the most conserved RSV gene across all known genetic clades,
and is also expressed most abundantly during viral replication
(David and Knipe, 2001; Johnson and Collins, 1989). For these rea-
sons, the N gene was  chosen as the target of a novel real-time
RT-PCR diagnostic tool, to provide quantitative viral load analy-
sis and discrimination between RSV A and B within a single assay.
Open access under CC BY license.The quantitative assay was  compared to a commercial conven-
tional multiplex PCR method (SeeplexTM RV detection kit, Seegene,
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espiratory samples from a study (Do et al., 2011) on acute respira-
ory infection in children at the Hospital for Tropical Diseases, Ho
hi Minh City, Vietnam. Here, the development and validation of
his assay is reported, as well as initial observations regarding sub-
roup diversity within Vietnamese RSV strains, and relationships
etween viral load and disease severity in Vietnamese patients.
. Methods
.1. Clinical specimens
To develop and evaluate this novel RSV diagnostic, 264 respi-
atory samples, collected and stored as part of a study on acute
espiratory infection among 309 children at the Hospital for Trop-
cal Diseases, Ho Chi Minh City, Vietnam were used (Do et al.,
011). Specimens were kept at 4 ◦C for a maximum of 24 h and then
liquoted and stored at −80 ◦C until further processing. The sam-
les comprised 240 nasopharyngeal aspirates, 23 throat swabs, and
 nasal swab collected in viral transport medium, and represented
ases admitted to the pediatric intensive care unit (ICU) (61/264,
3%) as well as the pediatric respiratory ward (203/264, 77%). One
undred and forty-one (53%) samples were from patients less than
 years old, 113 (42%) from 2 to 5 years old, 11 (4%) over 5 years
ld.
All samples were analyzed in parallel by the commercial mul-
iplex SeeplexTM RV detection kit (Seegene, Inc., Seoul, Korea)
ccording to the manufacturer’s instructions, to determine the
resence of 12 respiratory viruses: human RSV subgroups A and
 (RSV A, RSV B); inﬂuenza virus A (InfV A); inﬂuenza virus B (InfV
); human coronaviruses (229E, OC43), human metapneumovirus
hMPV), parainﬂuenza virus 1, 2 and 3 (PIV1, 2, 3), human rhi-
ovirus (hRV A) and adenovirus (AdV) (Kim et al., 2009; Roh et al.,
008) and by the newly developed RSV LNA real-time RT-PCR.
.2. RNA extraction and cDNA synthesis
RNA was extracted from 100 L of specimen and eluted in 60 L
n the Easy MAG  2.0 system (bioMérieux, Marcy l’Étoile, France). An
nternal RNA-virus control (equine arteritis virus [EAV]) was  added
o each sample prior to extraction at a standard concentration yield-
ng Ct values of 30–35 as previously described (Scheltinga et al.,
005). RNA was reverse transcribed using Superscript III reverse
ranscriptase (Invitrogen, Carlsbad (CA), USA) and random hex-
mers (Roche, Mannheim, Germany). Each 20 L reaction mixture
ontained 5 L extracted RNA, 1X RT-buffer (Invitrogen), 0.5 mM of
ach dNTP (Roche), 2 ng random hexamer, 10 mM DTT (Invitrogen),
 U of RNAse inhibitor and 2 U RT Superscript III. cDNA synthesis
as performed using an Eppendorf Master thermocycler gradient
ystem (PerkinElmer Corporation, Foster City (CA), USA) under the
ollowing conditions: 10 min  at 25 ◦C, 60 min  at 50 ◦C and 15 min  at
5 ◦C.
.3. Assay development
The assay was designed to detect all known RSV strains and to
ifferentiate RSV subgroups A and B. Primers (MTH1 and MTH2B)
ere selected using Primer Express software v2.0 (Applied Biosys-
ems Inc., Foster city (CA), USA) and a dataset of 45N gene sequences
vailable from the NCBI database (Table 1) to amplify 84 bp
or both RSV A and RSV B. RSV subgroups A and B differ by 5
ucleotides within the highly conserved region of the N gene;
wo LNA probes, RSVA and RSV B (Sigma Proligo, Singapore),
ere designed to include three LNA residues at these sites (+T,
A and +T for RSV A; +C, +G and +A for RSV B). The choice
f reporters and compatible quenchers was based on a Bio-Rad
uideline (Biorade, 2006). Primers and probes were analyzed for Methods 179 (2012) 250– 255 251
false priming sites, hybridizations, and secondary structures at
http://lnatools.com/hybridization. Plasmids containing the ampli-
cons from RSV A and RSV B clinical strains were constructed for use
as positive controls and generation of standard curves for quanti-
tation. Brieﬂy, target cDNAs ampliﬁed via RT-PCR from RSV A and
RSV B-positive clinical specimens as identiﬁed by SeeplexTM RV
detection kit, were cloned into pCRII®-TOPO® vector and trans-
formed into the TOPO-10 bacterial strain using the TOPA TA cloning
kit (Invitrogen). Clones were screened by PCR using M13  primers,
and conﬁrmed by sequencing (CEQ DTCS Quick Start Kit, CEQ 8000
Capillary Sequencer, Beckman Coulter, Inc., Fullerton (CA), USA).
Quantitation of the plasmid preparations (ng/l) was conducted
using PicoGreen dsDNA Quantitation Reagent (Invitrogen) in dupli-
cate, and the corresponding copy number of target cDNA in the
plasmid was calculated (copies/mL). Serial 10-fold dilutions were
made for analysis of analytical sensitivity and used as standard
curves for viral load quantitation. Viral load was expressed as copies
per mL  of sample, A Ct-value of 45 was  chosen as a cut-off value for
standard positivity.
2.4. Assay protocol
The RSV LNA assay was  performed on a DNA Engine Peltier Ther-
mocycler and Chromo 4 Real-time PCR system detector (Bio-Rad,
Hercules, USA), in a total volume of 25 l containing 5 ul template
cDNA, 0.05 U Hotstart Taq (Invitrogen), 1× PCR Buffer, 5 mM MgCl2,
0.2 mM  of each dNTP (Roche), 0,4 M of each primer (RSV and EAV),
0.2 M of each probe for RSV, and 0.12 M of EAV probe (Table 1).
The PCR employed the following thermal cycler settings: 15 min
at 95 ◦C, followed by 45 cycles of 30 s at 95 ◦C and 1 min at 45 ◦C.
Negative controls and standards were included in every assay run.
The number of RSV RNA transcripts (copies/mL) of clinical samples
was  determined based on the standard curve. A Ct-value of 45 was
chosen as the cut-off value for sample positivity. All clinical sam-
ples required a Ct value of 30 to 35 for the EAV internal control to
be considered valid.
Potential interference between primers/probes for target (RSV)
and internal control (EAV) was assessed by running serial dilutions
of two clinical samples with conﬁrmed high viral loads of RSV A
and RSV B (data not shown).
2.5. Assay performance assessment
The analytical limit of detection was determined using
six 10-fold dilutions of control plasmids from 9.0 × 101 to
9.0 × 106 copies/mL for RSV A and 6.0 × 102 to 6.0 × 107 copies/mL
for RSV B. The viral load in clinical samples was  assessed by
running them in parallel with quantitative standards. Since the
concentration of target cDNA in plasmid controls was  known, the
corresponding concentration of cDNA in the clinical sample could
be estimated. Samples that tested positive by RSV LNA but not
by Seeplex were further conﬁrmed by a seminested RT-PCR tar-
geted at the second hypervariable region of the RSV G gene as
described previously (Parveen et al., 2006). Speciﬁcity of the assay
was  assessed by presence of non-RSV viruses within the sample
set (as determined by Seeplex). Speciﬁcity was further assessed by
attempted ampliﬁcation of culture supernatants of selected human
seasonal inﬂuenza isolates [A/Sydney/5/97(H3N2), A/New Caledo-
nia/20/99(H1N1), B/Yamanashi/166/98].
2.6. Statistical analysisStatistical comparisons between Seeplex RT-PCR and the RSV-
LNA assay were performed using McNemar’s test. Assay variability
was  quantiﬁed by the standard deviation (SD) and coefﬁcient
of variation (CV). Ct-values (of ﬁve 10-fold dilutions of control
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Table  1
Nucleotides sequences of primers and probes. LNA residues are shown in upper case and with a (+) sign in front.
Primers/probes name Target Nucleotide sequences
MTH1 (forward) RSV N genea GGATTCTACCATATATTGA
MTH2B (reverse) GAAGTKAGGAAATTGAGT
probe A0108 LNA (RSV A) HEX-5′-ca + Aaagc + At + Cat + Ta + Tt + Atc + Ttt-BHQ1
probe  B0108 LNA (RSV B) FAM-5′-caaaagcatcattg + Ct + Gtc + Att-BHQ1
FW EAVb CATCTCTTGCTTTGCTCCTTAG
as  RV AGCCGCACCTTCACATTG
probe 5′-Cy5-CGCGCTCGCTGTCAGAACAACATTATTGCCCACAGCGCG-BHQ3-3′
















































other cases: median (IQR) of viral load (copies/mL) in the 17 pedi-
atric ICU RSV positive samples was  3.8 × 107 (1.6 × 106 to 1.6 × 108)
versus 2.5 × 106 (4.5 × 104 to 1.6 × 107) in the 58 positive samples
from other wards (Mann–Whitney U test, p = 0.02). An association39662, DQ780563 – DQ780569, AY151194 – AY151199, U63644, U50362, AF03
J492156 – AJ492157, AJ492160 – AJ492161, AF013254, AF013255.
b Nucleotide sequences of the internal control were obtained from Scheltinga et 
lasmids) for inter- and intra-assay variability were estimated
sing a linear random effects model. For the comparison of
ndependent groups, the Fisher exact test was used for cate-
orical data and the Mann–Whitney U test for continuous data.
he Mann–Whitney U test was used to compare the viral load
copies/mL) between the following groups: severe vs. non-severe
SV disease, RSV subgroups A vs. B, single RSV infection vs. co-
nfection with other respiratory viruses. Severe RSV disease was
eﬁned by the need for pediatric ICU admission. All statistical tests
ere conducted at the two-tailed 5% signiﬁcance level. Analyses
ere performed with R 2.9.1 and the contributed R package lme4
R Foundation for Statistical Computing, Vienna, Austria) and Inter-
olled Stata 9.2 (College Station, TX, USA).
. Results
.1. Assay performance
The analytical limit of detection was determined using six
0-fold serial dilutions of control plasmid in sextuplicate. 100%
etection was observed at concentrations ranging from 9.0 × 102 to
.0 × 106 copies/mL for RSV A and 6.0 × 103 to 6.0 × 107 copies/mL
or RSV B. The detection rate was 33% (2/6) for 9.0 × 101 copies/mL
f RSV A and 50% (3/6) for 6.0 × 102 copies/mL of RSVB. Signiﬁcant
egative linear relationships were observed between copies/mL
nd Ct values for the ﬁrst ﬁve 10-fold dilutions from 9.0 × 102 to
.0 × 106 copies/mL for RSV A (adjusted R2 = 0.97) and 6.0 × 103 to
.0 × 107 copies/mL for RSV B (adjusted R2 = 0.99). To assess the
nalytical intra- and inter-assay reproducibility of the ampliﬁca-
ion step of the assay, Ct values were compared between replicates
f ﬁve 10-fold serial dilutions tested in the same batch (Table 2) or
n different days (Table 3). Coefﬁcient of variation (CVs) for ana-
ytical intra-assay variability of RSV A and B ranged from 0.9 to 3.3
nd 0.6 to 3.2, respectively. Similarly, CVs for analytical inter-assay
ariability of both RSV A and B ranged from 1 to 3. Speciﬁcity of
he assay was conﬁrmed by failure to amplify from 81 specimens
nown to contain other respiratory viruses (as detected by Seeplex
ssay). These included inﬂuenza viruses (n = 38), rhinovirus (n = 10),
uman coronavirus (n = 14), human metapneumovirus (n = 11),
arainﬂuenza virus (n = 14), and adenovirus (n = 6). In addition, no
mpliﬁcation was observed for culture supernatants containing
igh titer inﬂuenza viruses.
.2. SeeplexTM RV detection kit vs. RSV LNA real-time RT-PCR
Among 264 samples, the assay detected signiﬁcantly more RSV
ositives than the multiplex Seeplex kit (84/264 [31.8%] vs 64/264
24.2%], p-value McNemar test <0.001). The additional 20 samples
ositive by the RSV LNA assay were conﬁrmed using an RSV G gene
T-PCR (Parveen et al., 2006). None of the samples negative by RSV
NA assay were positive by Seeplex. Fluorescence signals of EAVAY911262, AJ492155 – AI492167, D00736, NC 001781, AY151200 – AY1512007,
05).
internal control were detected for all tested samples at Ct values
ranging from 30 to 35.
The viral load of RSV detected in 84 samples ranged from
4.0 × 103 to 109 copies/mL (median value 2.9 × 106; interquartile
range (IQR) 2.7 × 105 to 4.2 × 107). Median (IQR) of viral load in 64
positive samples by both the RSV LNA assay and the Seeplex kit
was  8.0 × 106 copies/mL (2.0 × 105 to 5.0 × 107). In the 20 samples
positive by RSV LNA assay alone, median (IQR) of viral load was
3.5 × 104 copies/mL (1.7 × 104 to 4.3 × 105). There was  a signiﬁcant
difference observed in viral load between RSV positive samples
diagnosed by both assays and RSV positive samples by only RSV
LNA assay (Mann–Whitney U test, p = 0.001) (Fig. 1).
3.3. RSV subgroups, and relationships between viral load and
disease severity
Among 84 RSV positive samples, 53 were identiﬁed as RSV A
(63%) and 31 as RSV B (37%). There was  100% concordance in sub-
group identiﬁcation between the RSV LNA assay and the Seeplex
kit. No association was found between RSV subgroups and dis-
ease severity, based on the distribution of cases between pediatric
intensive care unit (ICU) and other wards. Similarly, no signiﬁcant
differences were observed in viral load between RSV subgroups.
Overall, a total of 29% (17/61) of patients with severe presenta-
tions (pediatric ICU admissions) were RSV positive, whereas 33%
(67/203) of patients on other wards were RSV positive (Fisher’s
exact test p = 0.45). Viral loads in nasal pharyngeal aspirates of
pediatric ICU patients were signiﬁcantly higher when compared toFig. 1. Viral load detected in RSV positive samples diagnosed by both assays and
RSV positive samples by only LNA assay.
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Table  2
Analytical intra-assay reproducibility of RSV LNA assay.










9.0 × 106 22.4 0.3 1.4 6.0 × 107 24.5 0.5 2.2
9.0  ×105 25.4 0.2 0.9 6.0 ×106 28.3 0.9 3.2
9.0  ×104 29.1 0.3 1.0 6.0 × 105 31.9 0.5 1.6
9.0  × 103 32.7 0.4 1.2 6.0 × 104 35.7 0.5 1.3



























fll values are calculated from Ct values of six replicates at each concentration.
D:  standard deviation.
V: coefﬁcient of variation.
etween higher age and lower log-VL was also found (correlation
0.19; p = 0.09) among RSV positive patients, and younger age was
ssociated with more severe disease (correlation 0.27, p = 0.02).
hen the dataset was adjusted for age, differences between viral
oad and severity lost statistical signiﬁcance (data not shown).
No signiﬁcant differences in RSV viral load were observed
etween patients with single infections versus co-infections, or
etween patients requiring oxygen versus patients who  did not.
.4. Viral co-infection
Detection by Seeplex assay revealed an overall co-infection level
f 20% (17/84). These included Inﬂuenza viruses (n = 8), parain-
uenza viruses (n = 3), coronaviruses (n = 1), adenovirus in (n = 2),
uman metapneumovirus (n = 3) and rhinovirus (n = 1). The RSV
NA assay revealed an additional 20 RSV positive samples, none
f which were coinfected. The prevalence of coinfection of RSV
ositive samples was 19% for RSV A (10/53); 23% for RSV B (7/31).
. DiscussionRSV was the pathogen detected most frequently among hospi-
alized children with acute respiratory infection in a prospective
tudy conducted between 2004 and 2008 in pediatric ICUs and
able 3






9.0 × 106 22.4 0.2 
9.0  × 105 25.9 0.2 
9.0  × 104 29.6 0.3 
9.0  × 103 33.1 0.3 
9.0  × 102 36.8 1.0 





6.0 × 107 24.76 0.2 
6.0  × 106 25.22 0.6 
6.0  × 105 31.76 0.5 
6.0  × 104 35.39 0.6 
6.0  × 103 38.79 1.0 
D standard deviation.
V coefﬁcient of variation.
ach concentration (from high to low) was run in duplicate (for ﬁrst two  dilutions), quad
ach  run.
a Mean was  calculated from Ct values of replicates of each concentrations from all days
b Standard deviations calculated from Ct values of replicates of each concentrations fro
or  within- and between-run variation.
c Coefﬁcient of variation was deﬁned as the SD divided by the mean (%).respiratory wards of the Hospital for Tropical Diseases in Ho Chi
Minh City, Viet Nam (Do et al., 2011). Rapid and sensitive detection
of RSV is important for installing infection control measures and
thus preventing nosocomial spread, which has been recognized as
a major risk in pediatric wards (Macartney et al., 2000). Several RT-
PCR based methods and real-time RT-PCR have been described for
RSV detection (Borg et al., 2003; Dewhurst-Maridor et al., 2004; do
Nascimento et al., 2008; Falsey et al., 2003; Gueudin et al., 2003; Hu
et al., 2003; Kuypers et al., 2006, 2004; Mentel et al., 2003; Perkins
et al., 2005; van de Pol et al., 2006, 2010; van Elden et al., 2003). An
improved PCR diagnostic tool using LNA probes targeting the most
conserved region of the N gene was developed, to detect and distin-
guish simultaneously subgroup A and B and to quantify viral RNA
load. An internal control virus (EAV) was added to each specimen
in order to monitor efﬁciency of RNA extraction, reverse transcrip-
tion, and ampliﬁcation. This assay exhibited an increased diagnostic
yield, from 24% to 32%, compared to a commercial conventional
multiplex PCR assay, the SeeplexTM RV detection kit, and produced
a diagnostic result within 4 h of sample receipt.
Previous studies have reported higher sensitivities of PCR
methods targeting the N gene, compared to methods target-
ing other genes (Perkins et al., 2005; Rohwedder et al., 1998).
Primers and probes were originally designed based on available















ruplicate (for third dilution) and in sextuplicate (for fourth and ﬁfth dilutions), in
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trains A2 and B. Twenty-four more recent submissions of N
ene sequences from Cambodia showed perfect matches to these
rimers and probes. This indicates that these primers and probes
heoretically could detect all currently known circulating strains of
SV. The 100% detection rate for 9.0 × 102 copies/mL for RSV A and
or 6.0 × 103 copies/mL for RSV B are in the same range as previ-
usly published methods that used dilution series of plasmid DNA
nd, when re-calculated and assuming a 1:1 RT efﬁciency, as meth-
ds that used RNA transcripts (ranging from 103 to 106 copies/mL)
Borg et al., 2003; Gueudin et al., 2003; Kuypers et al., 2004). Signiﬁ-
ant linear correlations of Ct values and copies/mL were observed at
evels of viral load typically found in clinical specimens. In addition,
he assay exhibited good analytical reproducibility as evidenced by
ntra- and inter-assay CVs ranging from 1% to 3%. CVs from other
eported diagnostic approaches (based on copies/mL) ranged from
% to 35.8% (Borg et al., 2003; Gueudin et al., 2003; Kuypers et al.,
004).
As RSV pathogenesis is multifactorial and varied (Collins and
raham, 2007), the relationships between disease severity, viral
oad and RSV subgroups were studied. Associations between RSV
iral load and disease severity have been reported previously
Buckingham et al., 2000; Fodha et al., 2007; Houben et al., 2010),
nd several studies have deﬁnitively shown a negative correlation
etween RSV viral load and age (Borg et al., 2003; Gueudin et al.,
003; Kuypers et al., 2004). The results of the current study con-
rm a negative correlation between RSV viral load and age, and
igniﬁcant difference in viral load between severe and non-severe
atients (deﬁned by admission status to the pediatric ICU versus
he Respiratory ward). However, when the dataset was  adjusted
or age, differences between viral load and severity lost statistical
igniﬁcance.
Previous studies have also suggested possible differences in
athogenicity between RSV A and B (Campanini et al., 2007; Gerna
t al., 2008; Kuypers et al., 2004; Perkins et al., 2005). Here we  report
o signiﬁcant differences in viral load or severity between RSV sub-
roups. Variations in sample collection may  also affect observed
iral loads, however sample collection for this cohort was con-
ucted by experienced and well-trained hospital personnel using
tandard operating procedures
In conclusion, this novel real-time RSV LNA assay offers a rapid,
peciﬁc, highly reproducible and more sensitive alternative (32%)
o a commercial multiplex RT-PCR (24%) for RSV detection, and in
ddition provides quantitation and subgrouping. This information
s useful for epidemiological surveillance and clinical decision-
aking.
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